Last update 19 Jul 2025

[18F]-Fluselenamyl

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
18F-FSA
Target
APP
Action
modulators
Mechanism
APP modulators(Beta amyloid A4 protein modulators)
Therapeutic Areas
Nervous System Diseases
Active Indication
Alzheimer Disease
Inactive Indication-
Originator Organization
Washington University School of MedicineWashington University School of Medicine
Active Organization
Washington University School of MedicineWashington University School of Medicine
Inactive Organization-
License Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with [18F]-Fluselenamyl
NCT06439992
/ RecruitingNot ApplicableIIT
Beta Amyloid PET Imaging for Alzheimer Disease: [18F]-Fluselenamyl (Alternative Vehicle) Comparison With [11C]-PIB (FSA-PIB AD)
100 Clinical Results associated with [18F]-Fluselenamyl
Login to view more data
100 Translational Medicine associated with [18F]-Fluselenamyl
Login to view more data
100 Patents (Medical) associated with [18F]-Fluselenamyl
Login to view more data
100 Deals associated with [18F]-Fluselenamyl
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseaseClinical
United States
Washington University School of MedicineWashington University School of Medicine
07 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free